SCHEMBL7749394

SCHEMBL7749394

Cc1c(CCC(=O)O)n(C)c2ccc(C(C)C)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 3/20 0.47
AR P10275 1/20 0.42
AKR1C4 P17516 1/20 0.42
PTGS1 P23219 1/20 0.42
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
AKR1C1 Q04828 1/20 0.42
KDM4E B2RXH2 2/20 0.40
GAA P10253 1/20 0.40
PTGES O14684 3/20 0.40
TBXAS1 P24557 1/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
ALOX15 P16050 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16156847 0.75 FABP4 (0.54) PTGES2KDM4EGAAPTGESUSP2
SCHEMBL8687445 0.73 PTGES2 (0.43) PTGES2PTGS1KDM4EGAAPTGES
SCHEMBL9156302 0.69 KDM4E (0.46) PTGES2KDM4EGAATP53MAPT
SCHEMBL12083594 0.69 RORA (0.46) PTGS1KDM4EGAAMAPTALDH1A1
SCHEMBL29510573 0.68 NPSR1 (0.59) PTGS1KDM4EGAAUSP5MAPT
SCHEMBL23612472 0.66 KMO (0.52) USP2TP53CYP1A2CYP2C9ALOX15
SCHEMBL24667912 0.66 BCHE (0.45) PTGS1KDM4EGAAUSP2MAPT
SCHEMBL12889909 0.65 USP5 (0.47) KDM4EGAAUSP2TP53CYP1A2
SCHEMBL7907419 0.65 AKR1C2 (0.51) ARAKR1C4PTGS1AKR1C3AKR1C2
SCHEMBL879572 0.65 ALDH1A1 (0.59) USP5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001034199-A2 ONCOLYTIC COMBINATIONS FOR THE TREATMENT OF CANCER ELI LILLY AND COMPANY (US) 2001-05-17 WO claimed
WO-2001034199-A2 ONCOLYTIC COMBINATIONS FOR THE TREATMENT OF CANCER ELI LILLY AND COMPANY (US) 2001-05-17 WO disclosed